At the meeting of shareholders in Dsseldorf the CEO Uwe Rhrhoff summarized the year as follows: The financial year 2010 went very successfully for us. Our products and services are very popular with o…
At the meeting of shareholders in Dsseldorf the CEO Uwe Rhrhoff summarized the year as follows: The financial year 2010 went very successfully for us. Our products and services are very popular with our international pharma customers. We achieved our targets and actually exceeded some of them. We wish to allow our shareholders to participate in this success. In the coming years we see further major growth opportunities, particularly in emerging countries. We want to become the leading global partner for solutions which contribute to improvements in health and wellbeing, Rhrhoff added. The dividend of EUR 0.50 per share is basically tax-free for shareholders based in Germany. No dividend was paid in the prior year. With capital stock representation of 68.27% the General Meeting passed the following resolutions on agenda items: ITEM 2: Appropriation of net earnings for the financial year 2010: votes in favour 99.99% ITEM 3: Formal approval of the actions of the members of the Management Board for the financial year 2010: votes in favour 96.34% ITEM 4: Formal approval of the actions of the members of the Supervisory Board for the financial year 2010: votes in favour 98.52% ITEM 5: Election of the auditor for the financial year 2011: votes in favour 99.69% Gerresheimer is an internationally leading manufacturer of high-quality speciality products made of glass and plastic for the global pharma and healthcare industry. The Group realizes revenues of around EUR one billion and has 10,000 employees at 45 locations in Europe, North and South America and Asia.